# CEFIXIME
> **ANDA218691** · Abbreviated New Drug Application (Generic) · Sponsor: FDC LTD · Approved 2026-05-14
## Drug
- **FDA Application Number:** ANDA218691
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CEFIXIME
- **Generic name:** Cefixime
- **Active ingredients:** CEFIXIME
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** FDC LTD
- **First approval:** 2026-05-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218691)
---
*MORVS · CC0 1.0*